Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug application study for protection against SARS-CoV-2 infection in adults with mild to moderate COVID-19
jRCTs031230405Completed
- Sponsor
- Nezu Life Sciences
- Start
- Oct 2023
- Countries
- 1
01
Overview
Single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Nezu Life Sciences. Primary endpoint: Safety Assessment. Started Oct 2023; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs031230405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230405.